Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
22%
ALSO IN PPH
PPH
27
HOLDINGS
46%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 23.2% | 8.2% |
|
MERCK & CO. INC. | 6.8% | 12.6% | 6.8% |
|
PFIZER INC | 7.2% | 5.1% | 5.1% |
|
ABBVIE INC | 7.7% | 3.7% | 3.7% |
|
JOHNSON & JOHNSON | 6.9% | 3.3% | 3.3% |
FTXH Overweight Relative to PPH
|
ABBVIE INC | 4.0% |
|
BIOGEN IDEC INC | 3.9% |
|
GILEAD SCIENCES INC | 3.9% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
AMGEN INC | 3.6% |
|
JOHNSON & JOHNSON | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
INCYTE CORP | 3.2% |
|
EXELIXIS INC | 2.6% |
FTXH Underweight Relative to PPH
|
ELI LILLY & CO | -15.0% |
|
MERCK & CO. INC. | -5.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.6% |
|
MCKESSON CORP | -4.6% |
|
CENCORA INC | -4.2% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.2% |
|
ASTRAZENECA PLC-SPONS ADR | -3.8% |
 |
NOVARTIS AG-ADR | -3.7% |
 |
SANOFI-AVENTIS-ADR | -3.3% |